Published On: November 15, 2022Categories: Company news

DIVERSA got selected by EIT Health’s Bridgehead program to access new markets, and we could not be happier. Keep reading to see what is coming!


A bridge between businesses and markets


EIT Health’s Bridgehead program aims to bring together European bio- and healthtech entrepreneurs to help their businesses in growing beyond their home market.

This fantastic program matches each scale-up with Catalysers: accelerators, incubators, and clusters with a proven track record in building, accelerating, and scaling-up life sciences companies.


DIVERSA’s Catalyser 


Now, this story has started. Some weeks ago, our Business Development Director Víctor A. Francis met Startup Project Manager Arantxa Encinas-López at BioRN Life Science Cluster Rhine-Neckar. There, expert Susanne Kuhlendahl, from Marcommotion, coached them to create awareness about DIVERSA in the German market.



Moreover, Victor introduced the company at the BioRN Life Science Cluster Rhine-Neckar Annual Conference in Heidelberg, an event of one of Germany’s strongest biotech hubs.

This non-profit network founded in 1996 supports a rich translational ecosystem by connecting the regional innovation stakeholders as well as representing and promoting biotech companies. More than 120 institutional members, such as Merck or Roche, form part of this hub.

Our Catalyser is internationally recognized as an academic center of excellence in different fields of biomedicine, as well as cutting-edge imaging and omics. It has then an enormous potential for translation into health applications.


Thanks, EIT Health’s Bridgehead organization, for giving us this opportunity. We are excited to see how far our drug delivery technology can get! Danke schön!